SCHEMBL28061413

SCHEMBL28061413

Cc1ccc(OC(=O)C2CCNC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HTT P42858 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 1/20 0.50
CYP2D6 P10635 1/20 0.50
LMNA P02545 1/20 0.44
ELANE P08246 2/20 0.42
HTR2C P28335 3/20 0.41
HTR2B P41595 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CHRNA7 P36544 1/20 0.40
ATM Q13315 1/20 0.40
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29175598 0.84 HTT (0.50) KMT2ASMN1; SMN2HTTTDP1ELANE
SCHEMBL28167146 0.84 ELANE (0.51) KMT2ASMN1; SMN2HTTTDP1ELANE
SCHEMBL5813373 0.84 ELANE (0.51) KMT2ASMN1; SMN2HTTTDP1ELANE
SCHEMBL30878614 0.84 LMNA (0.51) KMT2ASMN1; SMN2MEN1LMNAHTR2C
SCHEMBL24605352 0.81 KMT2A (0.68) KMT2ASMN1; SMN2HTTTDP1MEN1
SCHEMBL27947111 0.81 KMT2A (0.68) KMT2ASMN1; SMN2HTTTDP1MEN1
SCHEMBL12370833 0.81 KMT2A (0.68) KMT2ASMN1; SMN2HTTTDP1MEN1
SCHEMBL2741099 0.81 KMT2A (0.68) KMT2ASMN1; SMN2HTTTDP1MEN1
SCHEMBL4630575 0.81 HTR2C (0.62) KMT2ASMN1; SMN2HTTTDP1ELANE
SCHEMBL10291941 0.78 KMT2A (0.75) KMT2ASMN1; SMN2HTTTDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102803252-B Be used for the treatment of indole amides derivative and the related compound thereof of neurodegenerative disorders K.U. LEUVEN RESEARCH & DEVELOPMENT (BE) 2016-05-25 CN disclosed